FSK Reports Q1 NAV per Share of $18.83
Reports Q1 NAV per share $18.83. In a joint statement, Michael Forman, CEO and chairman, and Daniel Pietrzak, president and chief investment officer for FSK and Partner and Global Head of Private Credit at KKR, stated, "Our first quarter decline in net asset value was driven by investments which have impacted prior quarters, certain new non-accrual assets, and the impact of market-driven spread widening in certain segments of our portfolio. As we continue to address investments that have had an outsized impact on NAV, we are taking several strategic steps in an effort to improve the financial position of FSK and to enhance shareholder value. We believe FSK's current stock price underappreciates the long-term value associated with FSK's investment portfolio and the KKR Credit platform. The four strategic actions announced this morning underscore our confidence in FSK and align that level of confidence with shareholders."
Trade with 70% Backtested Accuracy
Analyst Views on FSK
About FSK
About the author

- Class Action Notification: The Schall Law Firm reminds investors of a class action lawsuit against FS KKR Capital Corp. (NYSE:FSK) for violations of securities laws during the period from May 8, 2024, to February 25, 2026, with a deadline for participation set for July 3, 2026.
- False Statements Allegations: The complaint alleges that FSK misled investors regarding the effectiveness of its portfolio restructuring activities, overstating portfolio valuations and leading to significant investor losses once the truth emerged.
- Dividend Program Misrepresentation: The company is accused of making false and misleading statements about the strength of its quarterly dividend program, which further exacerbated investor losses and undermined market confidence in its financial health.
- Legal Consultation Opportunity: The Schall Law Firm offers free consultations for affected shareholders, encouraging them to understand their rights, noting that the class has not yet been certified, meaning investors are not currently represented by an attorney.
- Lawsuit Background: Robbins Geller Rudman & Dowd LLP announces a class action lawsuit against FS KKR Capital Corp, alleging violations of the Securities Exchange Act of 1934, which could represent significant losses for investors who purchased its securities.
- Deteriorating Financials: FS KKR reported a net asset value of $21.93 per share in Q2 2025, a 6.2% decline from the previous quarter, with total fair value of investments dropping by $474 million, indicating a significant deterioration in the company's financial health.
- Portfolio Issues: The lawsuit claims FS KKR overstated the effectiveness of its portfolio restructuring, with non-accrual investments rising to 3.0%, highlighting serious challenges in managing investment risks that could undermine future investor confidence.
- Stock Price Reaction: Following the negative earnings report, FS KKR's stock price fell over 15%, reflecting market concerns about the company's financial condition, which may lead to decreased investor confidence in its future performance.
- Regencell Bioscience Lawsuit: A class action lawsuit against Regencell Bioscience Holdings Limited alleges that during the period from October 2024 to October 2025, the company failed to disclose market manipulation risks, exposing investors to significant financial risks and potential regulatory scrutiny, which could harm the company's reputation.
- SES AI Lawsuit Overview: The class action against SES AI Corporation claims that from January 2025 to March 2026, the company overstated its business prospects and failed to disclose logistics constraints that negatively impacted Q4 2025 revenues, raising concerns about its growth prospects for 2026 among investors.
- FS KKR Capital Lawsuit: FS KKR Capital Corp. faces a class action lawsuit alleging that from May 2024 to February 2026, the company exaggerated the effectiveness of its portfolio restructuring efforts, potentially misleading investors about its future distribution strategy and affecting market trust.
- Legal Consultation Information: Investors seeking more information about these class actions or their legal rights are encouraged to contact the Law Offices of Howard G. Smith, with provided contact details including phone and email, ensuring timely access to legal support.
- Legal Investigation Launched: Faruqi & Faruqi, LLP is investigating potential claims against FS KKR Capital Corp., aiming to provide legal support for investors who purchased the company's securities between May 8, 2024, and February 25, 2026.
- Investor Rights Reminder: The firm reminds investors that July 3, 2026, is the deadline to seek the role of lead plaintiff in a federal securities class action, emphasizing the importance of timely action to protect investor rights.
- Direct Contact Channels: Investors can directly reach out to Faruqi & Faruqi partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310) for detailed information regarding their legal rights.
- Focus on Potential Losses: The investigation targets investors who suffered losses during the specified period, indicating the firm's concern over potential legal issues surrounding FS KKR Capital, which may impact the company's future stock performance.
- Lawsuit Background: Bragar Eagel & Squire, P.C. has announced a class action lawsuit against FS KKR Capital on behalf of investors who purchased securities between May 8, 2024, and February 25, 2026, alleging that misleading statements led to investor losses during this period.
- Allegation Details: The lawsuit claims that FS KKR Capital overstated the effectiveness of its portfolio restructuring and investment valuations, failing to disclose the sustainability of its quarterly distribution strategy, which misled investors about the company's prospects.
- Investor Rights: Affected investors must apply by July 6, 2026, to be appointed as lead plaintiffs in the lawsuit, with Bragar Eagel & Squire offering free consultations to help investors understand their rights and options.
- Law Firm Overview: Bragar Eagel & Squire, P.C. is a nationally recognized law firm specializing in securities, derivative, and commercial litigation, representing both individual and institutional investors with extensive litigation experience.
- Declining Net Asset Value: FS KKR Capital reported a net asset value of $21.93 per share for Q2 2025, down $1.44 or 6.2% from the previous quarter, indicating increasing financial pressure that could undermine investor confidence.
- Worsening Losses: The company reported a loss per share of negative $0.75, down $1.18 or 274.4% from the prior quarter, highlighting significant issues in portfolio management that may lead to further stock price declines.
- Rising Non-Accrual Investments: Non-accrual investments rose to 3.0% and 5.3% of the total investment portfolio, compared to 2.1% and 3.5% in the previous quarter, indicating challenges in asset management that could impact future profitability.
- Dividend Cut: The company reduced its dividend from $0.70 to $0.48 per share, reflecting a cautious outlook on future cash flows, which may decrease investor confidence in the company's long-term growth prospects.











